<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <title>Submission 284 from Anon (session_user_id: 2c78721f7b22d0dba5e32de2e08ec776698bee55)</title>
    <link href="../../../export.css" rel="stylesheet">
  </head>
  <body>
    <h1>Submission 284 from Anon (session_user_id: 2c78721f7b22d0dba5e32de2e08ec776698bee55)</h1>
    <div class="field-name" id="d6002606a5ec3d03">Q1. Describe how DNA methylation is altered in cancer.
In your answer include the following points:
<br><p></p><ul><li>Describe the normal
function of DNA methylation at CpG islands.<br></li><li>Describe how DNA
methylation of CpG islands is disrupted in cancer.<br></li><li>Explain how disruption of
DNA methylation at CpG islands contributes to cancer.<br></li><li>Describe the normal
function of DNA methylation in intergenic regions and repetitive elements.<br></li><li>Describe how DNA
methylation in intergenic regions and repetitive elements is disrupted in cancer.<br></li><li>Explain how disruption
of DNA methylation in intergenic regions and repetitive elements contributes to
cancer.<br></li></ul><p></p></div>
    <div class="field-value"><p class="p0">DNA methylation at CpG islands silences the expression of certain genes by forming repressive chromatin structure as well as prohibiting transcription factor binding to DNA. In cancer cells, aberrant methylation at CpG islands is represented as hypermethylation of tumour suppressor genes and genome-wide hypomethylation which trigger the tumorigenesis.</p>
<p class="p0">  In normal cells, intergenic regions and repetitive elements are mostly methylated to maintain genomic stability. However, these regions and elements are usually hypomethylated in cancer cells which give rise to abnormal karyotype and activation of cryptic genomic elements and result in aberrant transcription of genes. In consequence, a normal tissue is transformed into a tumour.</p></div>

    <div class="field-name" id="323cdd9789545f83">Q2. Describe how disruption of imprinting can contribute to cancer, using the example of the H19/Igf2 cluster. In your
answer include the following points:
<br>
<p></p>
<ul>
    <li>Describe the methylation pattern of the paternal allele and how this determines
        Igf2 expression status.&nbsp;
        <br>
    </li>
    <li>Describe the methylation pattern of the maternal allele and how this determines
        Igf2 expression status.&nbsp;
        <br>
    </li>
    <li>Describe how imprinting at the H19/Igf2 cluster is disrupted in Wilm’s tumour.&nbsp;
        <br>
    </li>
    <li>Explain how disrupting imprinting at the H19/Igf2 cluster contributes to cancer.
        <br>
    </li>
</ul></div>
    <div class="field-value"><p class="p0">The imprint control region of H19/Igf2 cluster on the maternal allele is unmethylated while it is methylated on the paternal allele. The unmethylated maternal allele recruits CTCF4 to insulate the effect of enhancers in this region to Igf2 and therefore the enhancer will act on H19 while keeping Igf2 in silence. On the other hand, the methylated control region on paternal allele allows enhancers to act on Igf2 and get it expressed.</p>
<p class="p0">  In Wilm’s tumour, hypermethylation happens at imprint region on the maternal allele. Now both maternal and paternal allele have been methylated at these regions i.e. the loss of imprinting. In consequence, Igf2 on both allele get expressed. This double dose of Igf2 expression promote cell growth and eventually result in tumour.</p></div>

    <div class="field-name" id="961ab4c640df430a">Q3. The Economist article “<a href="http://www.economist.com/node/21552168" target="_blank">Cancer’s epicentre</a>” describes several drugs that affect
    epigenetic processes. Explain how Decitabine may be used to treat cancer,
    with reference to effects on the epigenome. In your answer include the
    following points:
<br>
<p></p>
    <ul>
        <li>Identify the class of epigenetic inhibitors that Decitabine belongs to.&nbsp;
            <br>
        </li>
        <li>Describe the impact of Decitabine on DNA methylation.
            <br>
        </li>
        <li>Describe how Decitabine can have an anti-tumour effect.&nbsp;
            <br>
        </li>
    </ul></div>
    <div class="field-value"><p class="p0"><span>Decitabine is a kind of DNA methyltransferase (DNMTi) inhibitors which act as nucleoside analogues getting incorporated into the DNA durning replication and then bind DNMTs irreversibly resulting in DNA demethylation. For fast replicating cells such as cancer cells, they are affected more severely. When Decitabine is used at a reasonably low does, it performs anti-neoplastic effect very well by inhibiting the growth of cancer cells.</span></p></div>

    <div class="field-name" id="10aa9d89e69a5f7a">Q4. Dr Stephen Baylin speculates in the Economist article that "epigenetic
drugs altered the tumour cells in some lasting way that made them more
susceptible to standard chemotherapy." How can drugs that alter DNA methylation
have effects that last beyond the period of drug treatment? Discuss whether
there are any periods of development when you would avoid treating patients
with such drugs. In your answer include the following points:
<br>
<p></p>
<ul>
    <li>Describe how altering DNA methylation can have enduring effects on the
        epigenome.
        <br>
    </li>
    <li>Define what is meant by a sensitive period.
        <br>
    </li>
    <li>Identify sensitive periods of development.
        <br>
    </li>
    <li>Explain why treating patients during sensitive periods would be inadvisable.
    <br>
</li>
</ul></div>
    <div class="field-value"><div class="Section0">
<p class="p0"><span>Changes of DNA methylation is mitoticly inheritable via cell division because methylation state is maintained by DNMTs. In this way, alternations of DNA methylation state caused by drugs have lasting effects beyond the period of drug treatment.</span></p>
<p class="p0"><span>  The sensitive period is a period of embryonic development that environmental factors can take great effects to epigenetic reprogramming. During the periods of embryo development, the blastocyst stage and formation of primordial germ cells are two sensitive stages. Exposure of drugs may affect normal epigenetic reprogramming in embryonic cells. Therefore sensitive periods would be avoided for treating patients.</span></p>
</div></div>
  </body>
</html>